“Running both simultaneously, optionality value, when to pull the trigger”
As the lead banker advising a founder-owned company's board on its exit process, you are tasked with explaining why running an IPO preparation track and an M&A sale process in parallel creates optionality value for the seller, and — using the figures below — determining whether the board should sign the M&A offer now or continue toward an IPO listing.
Task: explain why a dual-track process is more valuable to a seller than committing to either an IPO or an M&A sale alone, then use the numbers below to decide which path the board should pursue.
The board is evaluating TargetCo's exit options after receiving a signed indicative offer from a strategic buyer.
| Line Item | Value |
|---|---|
| TargetCo LTM EBITDA | $150.0m |
| Strategic Buyer Indicative Offer Multiple | 9.0x EBITDA |
| IPO Comparable Multiple Range (public peers) | 11.0x – 13.0x EBITDA |
| Estimated Public Market Window Risk | 15% (0.15) |
| M&A-Only Process Cost (advisory + legal) | $12.0m |
| IPO-Only Process Cost (underwriting + legal) | $30.0m |
| Incremental Cost of Running Both Tracks in Parallel | $20.0m |
| Board's Minimum Acceptable Net Proceeds | $1,400.0m |
M&A Enterprise Value = LTM EBITDA × Strategic Buyer Multiple
Using this formula, compute the enterprise value implied by the strategic buyer's offer.
IPO Enterprise Value (Midpoint) = LTM EBITDA × [(Low Multiple + High Multiple) / 2]
Using this formula, compute the midpoint enterprise value implied by public market comparables.
Risk-Adjusted IPO Enterprise Value = IPO Enterprise Value (Midpoint) × (1 − Market Window Risk)
Using this formula, compute the IPO value after discounting for the risk that market conditions deteriorate before listing.
Assume:
Using these inputs, determine whether the board should sign the M&A offer now or continue toward the IPO.
Try answering out loud first — then reveal the model answer and compare.
No comments yet — be the first to ask a question.